【结 构 式】 |
【药物名称】Detalliptinium, Datelliptium chloride, SR-95156B(monoHCl), NSC-311152, DTL 【化学名称】2-[2-(Diethylamino)ethyl]-9-hydroxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazolium chloride 【CA登记号】105118-14-7, 81531-58-0 (acetate), 81531-57-9 (free cation) 【 分 子 式 】C23H28ClN3O 【 分 子 量 】397.95211 |
【开发单位】ANVAR (Originator), CNRS (Originator), Sanofi-synthélabo (Originator), Sanofi-Synthelabo (Licensee) 【药理作用】Alkaloids |
合成路线1
By reaction of 9-hydroxyellipticine (I) with 2-(diethylamino)ethyl chloride (II) in DMF at 100 C.
【1】 Gros, P.; Crisafulli, E. (CNRS (Centre National de la Recherche Scientifique); Sanofi-Synthélabo); Hydrochlorides of 2-aminoalkyl-9-hydroxyellipticinium chloride derivs. and pharmaceutical compsns. containing them. EP 0209511; FR 2584409; JP 1987010084; US 4897398 . |
【2】 Eastland, G. Jr.; Prous, J.; Castaner, J.; DATELLIPTIUM CHLORIDE < Rec INN >. Drugs Fut 1989, 14, 2, 109. |
Extended Information